BRIEF published on 11/19/2025 at 23:05, 28 days 4 hours ago Les résultats financiers de Medicure pour le troisième trimestre 2025 reflètent une croissance du chiffre d'affaires malgré une perte nette. Marley Drug Croissance Des Revenus Perte Nette Ventes D'AGGRASTAT® Résultats Financiers De Mediure
BRIEF published on 11/19/2025 at 23:05, 28 days 4 hours ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 28 days 5 hours ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 1 month 4 days ago Medicure annoncera ses résultats financiers du troisième trimestre 2025 le 20 novembre Résultats Financiers Medicure Inc. Conférence Téléphonique Produits Pharmaceutiques Américains AGGRASTAT® Et ZYPITAMAG®
BRIEF published on 11/13/2025 at 23:35, 1 month 4 days ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 1 month 4 days ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 3 months 28 days ago Medicure publie ses résultats financiers du deuxième trimestre 2025 Résultats Financiers Perte Nette Revenu Net Investissement Dans La Recherche Entreprise Pharmaceutique
BRIEF published on 08/20/2025 at 23:35, 3 months 28 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 3 months 28 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 3 months 30 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
Published on 12/18/2025 at 00:55, 3 hours 5 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 4 hours ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 45 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 13 hours ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/18/2025 at 01:10, 2 hours 50 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 10 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 55 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 55 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 38 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 21 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 21 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 30 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 10 hours ago Outstanding Shares and Voting Rights Statement at 30 November 2025
